MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
BC Partners completed the acquisition of a 50% stake in Fedrigoni from Bain Captial for $1.6bn. (FS)
CVC Credit closes third European direct lending fund at €6.3bn. (FS)
You can access today’s complete newsletter?here.
Scroll down for more…
A group of EDF employee shareholders had appealed the French stock market regulator’s approval of the government’s $10.2bn bid to take the utility back into full state ownership, arguing the ongoing tender offer undervalues the company,?Bloomberg?reported.
FCPE Actions EDF and FCPE EDF ORS, which together own about 1.6% of the utility, filed the claim at the Paris appeals court on Friday.
Electricite de France is advised by Barclays , J.P. 摩根 and 摩根士丹利 . French Republic is advised by Cleary Gottlieb Steen & Hamilton LLP (led by?Pierre-Yves Chabert).
Valor Equity Partners , an operational growth investment firm, led a $1.48bn Series E round in Anduril Industries , a defense technology company, with participation from Founders Fund , Andreessen Horowitz , General Catalyst , 8VC , Lux Capital , Thrive Capital , DFJ Growth , Elad Gil, Lachy Groom, HUMAN CAPITAL , Marlinspike , WCM Investment Management , MVP Ventures , Lightspeed and US Innovative Technology Fund.
"Anduril has made incredible progress delivering on its mission to transform US and allied national security capabilities with advanced technology. Since its founding five years ago, Anduril has designed, built and fielded innovative capabilities at scale, at unprecedented speed. Anduril has a massive opportunity to create even more impact for the US and its allies, and we grow more confident in its mission with every opportunity to invest. Valor is excited to continue supporting the company operationally and financially as the business grows and scales," Antonio Gracias, Valor Equity Partners Founder, CEO and Chief Investment Partner.
BC Partners completed the acquisition of a 50% stake in Fedrigoni from Bain Captial for $1.6bn. (FS)
BC Partners , an international investment firm, completed the acquisition of a 50% stake in Fedrigoni Group , a global producer of self-adhesive labels and fibre-based packaging products, from Bain Capital , a global private investment firm, for $1.6bn.
This new partnership will support Fedrigoni's management team as they look to build on their successful track-record of M&A. BC Partners' owner-manager mindset has helped its portfolio companies execute over 400 add-on transactions over the last decade, and as such is the natural partner for Fedrigoni and Bain Capital to help drive value-creation opportunities.
Fedrigoni was advised by 贝恩公司 , New Deal Advisors SpA and Studio d’I comunicazione (led by? Stefania Vicentini ). BC Partners was advised by 普华永道 (led by? Giovanni Tinuper ,? Giuseppe Cerfeda ?and? Max Lehmann ), 贝恩公司 , AFRY , Canson Capital Partners , 高盛 , J.P. 摩根 , Nomura , Santander , Facchini Rossi Michelutti Studio Legale Tributario , White & Case LLP (led by? Michael Immordino ), Barabino & Partners (led by? Rossana Garavaglia ) and Kekst CNC (led by? Neil Maitland ). Bain Capital was advised by 摩根士丹利 , Rothschild & Co (led by?Nicola Paini?and? Irving Bellotti ), Kirkland & Ellis (led by? Jacob Traff ,?Adrian Christopher Maguire,? Matthew Merkle and? Neel Sachdev ), Latham & Watkins (led by? Cataldo Piccarreta ?and? Giorgia Lugli ), Pirola Pennuto Zei & Associati and Camarco (led by? Georgina Whittle ).
Prime Therapeutics , a management services company, completed the acquisition of Magellan Rx Management , a pharmacy benefits manager, from Centene Corporation , a publicly traded managed care company, for $1.35bn.
"This is a timely and important move. As pharmacy costs balloon, bold action is necessary. By bringing together the capabilities and talents of Prime and Magellan Rx, we are positioned to deliver breakthrough value to the clients and members we serve. We are excited about the solutions our shared teams will bring to the industry as we strive to deliver progress against the Quadruple Aim," Ken Paulus, Prime Therapeutics CEO and President.
Prime Therapeutics was advised by Solomon Partners , Fox Rothschild ?(led by?Timothy Scallen) and McDermott Will & Emery (led by? Mark Mihanovic ). Centene was advised by Allen & Company LLC. , Barclays , Evercore and Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates (led by? Jeremy London ).
CVC Credit closes third European direct lending fund at €6.3bn. (FS)
CVC Credit , the global credit management business of CVC, has held the final close of its third European Direct Lending fund?with €6.3bn ($6.6bn)?to deploy across the European Direct Lending opportunity, representing a significant increase over CVC’s prior European Direct Lending fund.
CVC Credit now manages total assets of more than €35bn ($37bn)?across its Performing Credit and Private Credit businesses. The Private Credit platform comprises its European Direct Lending and Capital Solutions strategies with assets of more than €10bn ($10.5bn).
Interested to find more??Sign up here?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here.